Assessment of genetically modified maize MON 89034 × 1507 × MIR162 × NK603 × DAS‐ 40278‐9 for food and feed uses, import and processing under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2018‐151)

Abstract

Stacked event MON 89034 × 1507 × MIR162 × NK603 × DAS‐40278‐9 (EFSA‐GMO‐NL‐2018‐151) is a genetically modified maize developed via conventional breeding. MON 89034× 1507 × MIR162 × NK603 × DAS‐40278‐9 plants contain the transgenes cry1A.105, cry2Ab2, cry1F, Vip3Aa20, cp4 epsps, pat, aad-1 and the phosphomannose isomerase (PMI) used as a selectable marker in the production of MIR162. MON89034 x 1507 x MIR162 x NK603 x DAS-40278-9 maize provides distinct sources for insect resistance combined with three distinct modes of herbicide tolerance: 2,4-D, glufosinate, and glyphosate. The scientific documentation provided in the application for genetically modified maize is adequate for risk assessment, and in accordance with EFSA guidance on risk assessment of genetically modified plants for use in food or feed. The VKM GMO panel does not consider the introduced modifications in event maize to imply potential specific health or environmental risks in Norway, compared to EU-countries. The EFSA opinion is adequate also for Norwegian considerations. Therefore, a full risk assessment of event MON 89034 × 1507 × MIR162 × NK603 × DAS‐40278‐9 was not performed by the VKM GMO Panel.

Assessment of genetically modified maize MON 89034 × 1507 × MIR162 × NK603 × DAS‐ 40278‐9 for food and feed uses, import and processing under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2018‐151)